Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
15.05.24
/
50%
€23.00
Target price
15.05.25
€45.11
Performance (%)
186.96%
Price
01.10.24
€65.50
Summary
This prediction is currently active. With a performance of 186.96% the BUY prediction by The_Goldman_Sachs_Gr is a big success. This prediction currently runs until 15.05.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Insmed Inc. | 0.769% | 0.769% |
iShares Core DAX® | 1.308% | 1.167% |
iShares Nasdaq 100 | -0.156% | 1.246% |
iShares Nikkei 225® | 1.270% | 0.293% |
iShares S&P 500 | 0.476% | 1.292% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $40.00 to $49.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat